2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Bladder Outlet Obstruction: new trials by email Literature Review of Bladder Outlet Obstruction trials Research Report on Bladder Outlet Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction solifenacin succinate, tamsulosin hydrochloride, Placebo to solifenacin - Lower Urinary Tract Symptoms, Bladder Outlet Obstruction | Phase 2 | Completed | Astellas Pharma Inc | 222 | 2007-06-01 | 2014-08-06 |
| A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) Mirabegron, Placebo - Lower Urinary Tract Symptoms, Bladder Outlet Obstruction | Phase 2 | Completed | Astellas Pharma Inc | 200 | 2006-12-01 | 2014-04-04 |
Lower Urinary Tract Symptoms (2) · Urinary Bladder Neck Obstruction (2) · Multiple Endocrine Neoplasia Type 1 (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urethral Diseases (2) · Urethral Obstruction (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1)
Solifenacin Succinate (1) · Tamsulosin (1) · mirabegron (1)
United States (2) · Belgium (1) · Canada (1) · Czechia (1) · Germany (1) · Hungary (1) · Poland (1)